TOP 10 COMPANIES IN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET

The Autoimmune Disease Diagnostics Market is Expected to Register a CAGR of 7.2% from 2023 to 2030 to Reach $9.84 Billion by 2030, according to Meticulous Research^®. The Autoimmune Disease Diagnostics Market includes reagents, kits, and assays. The growth in the Autoimmune Disease Diagnostics Market is mainly attributed to the increasing prevalence of autoimmune disorders, the growing emphasis on early diagnosis, and the rising awareness regarding autoimmune diseases. Emerging economies and increasing investments & funding in the autoimmune diseases space are expected to generate growth opportunities for the players in this market.

Here are the top 10 companies operating in the Autoimmune Disease Diagnostics Market

Abbott Laboratories (U.S.)

Founded in 1888 and headquartered in Illinois, U.S., Abbott Laboratories is engaged in the discovery, development, manufacturing, and sales of healthcare products. The company offers various products in diagnostics, medical devices, nutrition, and branded generic pharmaceuticals markets. Abbott operates worldwide through four business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

The company operates in the autoimmune disease diagnostics market through its Diagnostic Products business segment, which is further divided into Core Laboratory Diagnostics, Rapid Diagnostics, Point of Care Diagnostics, and Molecular Diagnostics business . The company offers protein reagents, immunoassay analyzers, and clinical chemistry analyzers in the autoimmune disease diagnostics market.

Abbott has a wide geographic presence and a strong distribution network in various countries through direct and indirect channels. The company has 90 manufacturing facilities globally, of which 24 manufacturing sites are engaged in developing diagnostic products. Some of its subsidiaries include Abbott Laboratories International LLC (U.S.), Abbott Diagnostics GmbH (Germany), Abbott Products Unlimited Company (Ireland), Abbott Diagnostics Medical Co., Ltd. (Japan), PT. Abbott Indonesia (Indonesia), and Alere Diagnostics GmbH (Germany).

 Hoffmann-La Roche Ltd (Switzerland)

Founded in 1896 and headquartered in Basel, Switzerland, F. Hoffmann-La Roche Ltd is a research-based healthcare company majorly engaged in creating innovative medicines and providing solutions for diagnostics. The company operates through two major business segments: Pharmaceuticals and Diagnostics, and offers centralized and point-of-care kits & reagents, advanced staining reagents, molecular diagnostic tests, and blood screening tests through its diagnostics division.

The Diagnostics segment is further categorized into Core Lab, Molecular Lab, Point of Care, Diabetes Care, and Pathology Lab. The Diagnostics segment manufactures equipment & reagents for research & medical diagnostic applications. The company offers assays and clinical chemistry analyzer systems for autoimmune diagnostics.

Hoffman-La Roche has 20 manufacturing sites and 27 research & development sites engaged in Pharmaceuticals and Diagnostics operations worldwide. Some of its subsidiaries across the globe are Roche Austria GmbH (Austria), Roche Diagnostics A/S (Denmark), Roche SAS (France), Roche Diagnostics GmbH (Germany), Roche Diagnostics Limited (Ireland), Roche Diagnostics S.p.A. (Italy), and F. Hoffmann-La Roche AG (Russia).

Siemens Healthineers AG. (Germany)

Founded in 1847 and headquartered in Erlangen, Germany, Siemens Healthineers AG is engaged in developing and selling a wide range of products, including medical imaging applications, laboratory diagnostics, and point-of-care testing. The company also offers digital health platforms for various clinical specialties and laboratories across the globe.

Siemens Healthineers operates in four business segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The company operates in the autoimmune disease diagnostics market through its Diagnostics segment. This segment offers clinical chemistry, immunoassay systems, and assays in the autoimmune disease diagnostics market.

Siemens has a direct presence in over 70 countries, including the U.S., Canada, Germany, the U.K., France, Italy, Spain, Denmark, Sweden, Switzerland, Belgium, India, China, Japan, Australia, New Zealand, and the Republic of Korea.

Thermo Fisher Scientific Inc. (U.S.)

Founded in 1956 and headquartered in Massachusetts, U.S., Thermo Fisher Scientific Inc. is a biotechnology company engaged in life sciences research, improving patient diagnostics, and increasing laboratory productivity. The company operates through four business segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services.

The company operates in autoimmune disease diagnostics through its Specialty Diagnostics segment. The segment is further sub-segmented into five businesses: Clinical Diagnostics, ImmunoDiagnostics, Microbiology, Transplant Diagnostics, and Healthcare Market Channel. The company offers assays, reagents, and kits through its Clinical Diagnostics segment.

Reagents kits & assays, and systems for clinical diagnosis of autoimmune diseases through its ImmunoDiagnostics segment in the autoimmune disease diagnostics market.

The company has a direct presence through its regional offices and production sites in the U.S., Mexico, Brazil, Germany, Belgium, Austria, the U.K., Italy, the Netherlands, South Africa, the UAE, India, China, Japan, Australia, and the Republic of Korea.

Bio-Rad Laboratories, Inc. (U.S.)

Founded in 1952 and headquartered in California, U.S., Bio-Rad Laboratories, Inc. is a distributor and manufacturer of clinical diagnostics products and systems & products for healthcare, analytical chemistry, and life sciences research. Bio-Rad Laboratories operates through two reportable segments: Clinical Diagnostics and Life Sciences.

The company operates in the autoimmune disease diagnostics market through its Clinical Diagnostics business segment. The company offers reagents, kits, antibodies, panels, and systems for diagnosing several systemic autoimmune diseases and gastrointestinal autoimmune diseases like celiac disease in the autoimmune disease diagnostics market.

The company has a direct distribution source in over 35 countries outside the U.S., including Afghanistan, France, Hong Kong, Japan, Korea, Iceland, Germany, Australia, Spain, the Netherlands, and South Africa.

Meticulous Research in its latest publication on Autoimmune Disease Diagnostics Market has predicted the growth of 7.2% during the forecast year 2023-2030.

 Beckman Coulter, Inc. (U.S.)

Founded in 1935 and headquartered in California, U.S., Beckman Coulter, Inc. develops and manufactures clinical diagnostics solutions. The company is also involved in developing and manufacturing automated laboratory solutions, including clinical information management tools, automated systems, and data analytics, among other things. Laboratory technicians and physicians use these solutions.

The company offers clinical chemistry analyzers and immunology analyzers in the autoimmune disease diagnostics market. Beckman Coulter is a subsidiary of Danaher Corporation (U.S.). Danaher Corporation operates in the autoimmune disease diagnostics market through its Diagnostics business segment.

Beckman Coulter has a global presence through its office locations and distributors. The company has offices in India, Australia, Japan, China, Argentina, Mexico, Bangladesh, China, Belgium, Brazil, Denmark, Chez Republic, France, Ireland, Israel, and Iran, among many other countries.

 Becton, Dickinson and Company (U.S.)

Founded in 1897 and headquartered in New Jersey, U.S., Becton, Dickinson and Company (BD) is a medical technology company that manufactures and sells a wide range of medical devices, laboratory equipment, and diagnostic products used by healthcare institutions, clinical laboratories, pharmaceutical companies, and research centers. The company operates in three business segments: BD Medical, BD Life Sciences, and BD Interventional.

The company operates in the autoimmune disease diagnostics market through its BD Life Sciences business segment (Biosciences). The BD Life Sciences segment is divided into Integrated Diagnostics Solutions and Biosciences. The company offers reagents and analyzers for autoimmune tests for diagnosis and research in the autoimmune disease diagnostics market.

Through its manufacturing and sales operations, BD has a direct presence in the U.S., Brazil, Canada, China, France, Spain, the U.K., Germany, Hungary, India, Ireland, Israel, Italy, Japan, Mexico, Singapore, and the Netherlands. The R&D facilities of the company are in China, France, India, Ireland, the U.S., and Singapore. BD has a wide global distribution network and markets its products through independent distribution channels and directly to hospitals, healthcare institutions, and independent sales representatives.

 PerkinElmer, Inc. (U.S.)

Founded in 1937 and headquartered in Massachusetts, U.S., PerkinElmer offers products, solutions, and services for the life sciences, diagnostics, and applied markets. It operates through two reportable business segments: Discovery & Analytical Solutions and Diagnostics. The company operates in the autoimmune disease diagnostics market through its Diagnostics business segment.

The company offers instruments for immunoassays, chemiluminescence, and ELISA. The company also offers related reagents and assays in the autoimmune disease diagnostics market. PerkinElmer offers most of the products for autoimmune disease testing through its subsidiary EUROIMMUN Medizinische Labordiagnostika AG (Germany).

PerkinElmer’s manufacturing and R&D facilities are in several countries, including the U.S., China, Japan, and Germany. Furthermore, the company has a strong network of sales and marketing channels and service personnel in over 38 countries and sells its products and services in over 190 countries.

 Grifols, S.A. (Spain)

Founded in 1909 and headquartered in Barcelona, Spain, Grifols, S.A. is a developer, manufacturer, and marketer of plasma-derived medicine, diagnostics solutions, and biologics. The company operates through four business segments: Plasma Procurement and Biopharma, Diagnostic, Bio Supplies, and Others.

The company operates in the autoimmune disease diagnostics market through its Diagnostic business segment. The company offers automated systems, assays, and reagents in the autoimmune disease diagnostics market.

The company has a direct presence worldwide through its facilities, R&D, and diagnostic centers. The company has diagnostics centers in the U.S., Spain, Switzerland, and Australia. The company has R&D centers in the U.S., Germany, Switzerland, Spain, Andorra, and China. Some of the major subsidiaries of the company operating in the autoimmune diagnostics market are Diagnostic Grifols, S.A. (Spain), Medion Grifols Diagnostic AG (Switzerland), Medion Diagnostic GmbH (Germany), and Grifols Inc. (U.S.).

Creative Diagnostics (U.S.)

Founded in 2005 and headquartered in New York, U.S., Creative Diagnostics manufactures and supplies antibodies, viral antigens, assays, and reagents. The company also provides contract biologic R&D and manufacturing services to diagnostic manufacturers and GMP biologics manufacturing for the biopharmaceutical industry. The company operates in the autoimmune disease diagnostics market by offering ELISA tests, antigens, and antibodies to diagnose autoimmune diseases.

The company has a strong distribution network globally. The company has distributors in 34 countries, including Argentina, Austria, Bangladesh, Australia, Belgium, Brazil, China, India, France, Germany, Indonesia, Iraq, Italy, Japan, Malaysia, Mexico, Poland, South Africa, and South Korea.

Authoritative Research on the Autoimmune Disease Diagnostics Market – Global Opportunity Analysis and Industry Forecast (2023-2030)

Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:

• Recent financial performance
• Key products
• Significant company strategies
• Partnerships and acquisitions

The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.